- -- Select Language --
-
- Afrikaans
- Albanian
- Arabic
- Azerbaijani
- Basque
- Bengali
- Belarusian
- Bulgarian
- Catalan
- Chinese Simplified
- Chinese Traditional
- Croatian
- Czech
- Danish
- Dutch
- English
- Esperanto
- Estonian
- Filipino
- Finnish
- French
- Galician
- Georgian
- German
- Greek
- Gujarati
- Haitian Creole
- Hebrew
- Hindi
- Hungarian
- Icelandic
- Indonesian
- Irish
- Italian
- Japanese
- Kannada
- Korean
- Latin
- Latvian
- Lithuanian
- Macedonian
- Malay
- Maltese
- Norwegian
- Persian
- Polish
- Portuguese
- Romanian
- Russian
- Serbian
- Slovak
- Slovenian
- Spanish
- Swahili
- Swedish
- Telugu
- Thai
- Turkish
- Ukrainian
- Urdu
- Vietnamese
- Welsh
- Yiddish
Our Products
- Medicated Oil
- Guggulu
- Vati
- Churna
- Amalaki Churna
- Arjuna Churna
- Aswagandha Churna
- Aswagandhadi Churna
- Avipattikar Churna
- Bael Soonth Churna
- Chirayata Churna
- Dhatupaushtik Churna
- Haritaki Churna
- Hingvastaka Churna
- Jamun Churna
- Karela Churna
- Lavanbhaskar Churna
- Neem Patta Churna
- Panchasakar Churna
- Shikakai Churna
- Sitopaladi Churna
- Triphala Churna
- Yashtimadhu Churna
Jamun Churna
Introduction :
The powdered seed of Jawa Plum (or Jamun fruit) is widely used in the management of Type-2 Diabetes mellitus since time immemorial. It is an effective anti-diabetic that significantly helps lower raised blood sugar level and delays the onset of diabetic complications.
Actions :
Jamun Seeds significantly decrease serum glucose, insulin, insulin resistance, TNF-α, dyslipidemia, and pancreatic thiobarbituric acid-reactive substances and efficiently enhance β-cell function and pancreatic superoxide dismutase, catalase, and glutathione peroxidase antioxidant enzyme activities in Type-2 Diabetes mellitus1
Exerts positive effect on memory owing to its anti-amnesic effect2
The seeds significantly enhance islet cell regeneration3
Effectively lower post prandial hyperglycaemia owing to significant α-amylase inhibitory effect4
The seeds potentially reduce oxidative stress caused due to alcohol on Liver and Kidneys and protect against fatty degenerations in Liver and Kidney5
Possess significant antibacterial activity against multidrug-resistant human bacterial pathogens6
The seed powder also protects against peptic ulcerations by reducing gastric secretions. It also enhances mucin and mucosal glycoprotein production in stomach, which enhances the stomach’s mucus-lined protective layer.
Indications :
Jamun (Beej) Churna is extremely useful in the following conditions:
- Type-2 Diabetes mellitus
- Insulin Resistance
- Metabolic Syndrome
-
Gastritis and Peptic Ulcerations that frequently occur in Diabetes mellitus
Direction for use:
½ - 1 teaspoonful (3-6 g) twice daily with water 15-20 minutes before meals or as directed by the Physician.
Presentation
100 gm Pack
References:
- Sharma AK, Bharti S, Kumar R, et al. Syzygium cumini ameliorates insulin resistance and β-cell dysfunction via modulation of PPAR, dyslipidemia, oxidative stress, and TNF-α in type 2 diabetic rats. Journal of Pharmacological Sciences. 2012;119(3):205-13.
- Alikatte KL, Akondi BR, Yerragunta VG, et al. Antiamnesic activity of Syzygium cumini against scopolamine induced spatial memory impairments in rats. Brain & Development. 2012 Nov;34(10):844-51.
- Dusane MB, Joshi BN. Seeds of Syzygium cumini (L.) Skeels: potential for islet regeneration in experimental diabetes. Zhong Xi Yi Jie He Xue Bao (Journal of Chinese Integrative Medicine). 2011 Dec;9(12):1380-7.
- Saha S, Verma R. Inhibitory potential of traditional herbs on α-amylase activity. Pharmaceutical Biology. 2012 Mar;50(3):326-31.
- Hossain S, Chowdhury IH, Basunia MA, et al. Syzygium cumini seed extract protects the liver against lipid peroxidation with concurrent amelioration of hepatic enzymes and lipid profile of alcoholic rats. Journal of Complementary & Integrative Medicine. 2011 Jan;8(1).
-
Bag A, Bhattacharyya SK, et al. In vitro antibacterial potential of Eugenia jambolana seed extracts against multidrug-resistant human bacterial pathogens. Microbiological Research. 2012 Jun 20;167(6):352-7.